Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS stock has been good to many of our followers after we pounded the table at $52 last year.

We Believe In CVS

Lyft

Shopify

It's one of the best performing stocks of last year, and an upbeat guidance is taking its shares to new heights.

Lesser Known E-Commerce Platform Posts Blowout Quarter

CVS stock should attract both income and growth investors as it leads the trend of managed care against competitor UnitedHealth.
The post Income and Growth Investors Will Benefit as CVS Adopts Managed Care appeared first on InvestorPlace.

Income and Growth Investors Will Benefit as CVS Adopts Managed Care

CVS (stock ticker: CVS) Weekly Chart Grid CVS reported earnings that broadly beat the street’s estimates on Wednesday, February 12. CVS reported adjusted EPS of $1.73, which beat estimates of $1.68.

CVS Earnings Beat Estimates, Stock Price Heading Higher

The company has shifted its business model successfully.

CVS Posts Strong Q4, Full-Year Earnings

Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.

Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - February 13, 2020

CVS Health’s strategy to reformat hundreds of drugstores into “HealthHubs” is to first integrate new healthcare options in markets where there are Aetna health plan members.

CVS Health Hubs Target Aetna Members As Rollout Escalates

Micron Technology

CyberArk Software

CyberArk, CVS Health, Shopify, Lyft and Micron were our top stock trades for Thursday. That said, let's look at the charts now.

5 Top Stock Trades for Thursday: MU, LYFT, SHOP, CVS, CYBR

CVS Health Corporation (CVS) CEO Larry Merlo on Q4 2019 Results - Earnings Call Transcript

The growing healthcare conglomerate outperformed forecasts in the fourth quarter, and boosted its outlook for the year ahead.

CVS Health Just Beat Expectations and Raised Some

The healthcare giant had good news in Q4, but achieving growth going forward could be more challenging.

The 3 Most Important Things to Know About CVS Health's Q4 Earnings Results

When CVS Health Corp. (NYSE: CVS) reported its most recent quarterly results before the markets opened on Wednesday, the pharmacy chain posted $1.73 in earnings per share (EPS) and $66.9 billion in revenue.

Is CVS Back on Track With Q4 Results?

CVS Health (CVS) registers strong growth in Pharmacy Services, benefiting from the upside in specialty services.

CVS Health (CVS) Q4 Earnings Top Estimates, Margins Improve

Shares of drugstore chain CVS Health Corp. (NYSE:CVS) rose on Wednesday morning on the back of strong fourth-quarter and full-year 2019 earnings results that were boosted by higher sales in its pharmacy benefit management business.

CVS Health Shares Gain on Strong 4th Quarter

Shopify (SHOP) impressed investors with a big beat on both top and bottom lines: 43 cents per share versus 23 cents expected, on $505.2 million which easily surpassed the Zacks consensus $482.3 million.

Shopify, CVS Outperform in Q4, Plus COVID-19 Update

Cisco Systems

CVS and CSCO are highlights on the earnings calendar today, and CSCO is worth a look for any hints into corporate spending on IT. Virus fears seem to be slowing down a bit, and it seems unlikely Fed Chair Powell will say anything too surprising in his second day of testimony.

CVS And Cisco Highlight Today’s Earnings Calendar, With More Powell Testimony On Way

CVS Health said a big boost in enrollment in seniors signing up for Medicare Advantage plans and new “health hub” formats in its stores are helping boost profits.

Health Hubs And Medicare Advantage Boost CVS Health

CVS Health (CVS) delivered earnings and revenue surprises of 2.98% and 4.16%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) Surpasses Q4 Earnings and Revenue Estimates

CVS Health Corp. CVS, +0.82% reported Wednesday fourth-quarter profit and revenue that beat expectations, but the drugstore chain's stock slipped 0.5% in premarket trading after running up 10% amid a six-day win streak through Tuesday.

CVS Health's stock turns higher after profit and revenue beats

CVS Health report Wednesday fiscal fourth-quarter earnings and revenue that beat Wall Street's expectations.

CVS Health beats on fourth-quarter earnings and revenue

We'll get earnings from CVS Health and Cisco Systems, as well as Federal Reserve Chairman Jerome Powell's second day of testimony to Congress.

CVS Health and Cisco earnings, Powell's second day on the Hill: 3 things to watch on Wednesday

On Wednesday, February 12, CVS Health (NYSE: CVS) will report its last quarter's earnings.

Q4 Earnings Outlook For CVS Health

CVS Health Corp. (NYSE: CVS) is set to report its fourth-quarter financial results before the markets open on Wednesday.

Is CVS Set to Wow Investors With Q4 Earnings Wednesday Morning?

CVS Health will increase investments in affordable housing to address social determinants of health as insurers intensify strategies to reduce costs and improve outcomes beyond covering traditional medical treatments.

CVS Ramps Up Housing Investments To Address Social Determinants

Expanded claims volume and better purchasing economics are expected to have aided CVS Health's (CVS) top line in Q4.

News for CVS Health Stock (CVS)